

Cerebral had a difficult few years. Here's what that means for you in 2026.
Online therapy and medication management, with insurance. The platform restructured significantly after regulatory scrutiny in 2022. The current model is more limited — and more defensible.
We've tested 34+ platforms. This review reflects hands-on experience, not marketing copy.
Cerebral at a Glance

Cerebral
Online therapy and medication management — restructured, with insurance
In 2022, Cerebral became one of the highest-profile examples of what went wrong in the telehealth boom. The company faced a DEA investigation related to its prescribing practices for stimulant medications — specifically, concerns that ADHD diagnoses and stimulant prescriptions were being issued too readily, driven partly by growth incentives that weren't appropriate for clinical decision-making. The DEA inquiry was serious. Cerebral stopped prescribing stimulants in 2022. The company also settled an FTC complaint related to its cancellation practices. Its leadership changed. It lost a significant portion of its user base.
That's the history, stated plainly. What followed matters too: Cerebral restructured its clinical protocols, brought in new oversight, and refocused on non-controlled medications — antidepressants, anti-anxiety medications, mood stabilizers. The platform still offers combined therapy and medication management, accepts several major insurance plans, and operates at a lower price point than many competitors. The question isn't whether the history happened — it did — but whether the current platform is trustworthy for the narrower use case it now occupies. Our assessment: yes, for non-controlled medication management, with the full context in hand.
Pricing & Plans
Cerebral charges a monthly subscription for its services. Medication management alone starts around $99/month. A combined therapy and medication management plan runs approximately $325/month. Several insurance plans are accepted — Aetna, Cigna, and others — which can significantly reduce your out-of-pocket cost depending on your benefits. The medication cost itself is separate from the subscription and billed through your pharmacy. Confirm your specific carrier's coverage before signing up, as in-network status varies by plan and state.
Knowing a platform's history isn't grounds for automatic disqualification — but it is grounds for going in with clear expectations about what you're choosing and why. Cerebral's narrower current scope is both a consequence of what happened and a reason to feel more comfortable with it for the right use case.
What Works Now
Where It Falls Short
Who Cerebral Is Best For (Now)
Who Should Look Elsewhere
How Cerebral Compares
| Cerebral | Brightside | Talkspace | |
|---|---|---|---|
| Price | $99–325/mo | $95–349/mo | $69–109/wk or copay |
| Insurance | Yes — several plans | No | Yes — Aetna, BCBS, Cigna, UHC |
| Therapy + Medication | Yes | Yes | Yes |
| ADHD stimulants | No (stopped 2022) | No | Limited |
| Depression/anxiety meds | Yes | Yes | Yes |
| Regulatory history | DEA + FTC issues 2022 | Clean | Clean |
| Rating | 3.7/5 | 4.2/5 | 4.3/5 |
Our Verdict
Cerebral is not the platform it was in 2021, for better and for worse. The worst excesses of the telehealth boom — loose stimulant prescribing, growth-over-care incentives — got addressed through regulation and restructuring. What's left is a more limited platform: combined therapy and non-controlled medication management, with insurance accepted. If that's what you need, it works. If you need ADHD stimulant management, or you'd rather not use a platform with this history, there are clean alternatives. We've listed them. Go in informed either way.
Affiliate link — we may earn a commission if you sign up, at no extra cost to you.
Coming Soon — Check BackAbout Our Editorial Process
DTS Research Team Editorial
Medication Management · Regulatory Context · Platform Research
Every recommendation on this page was independently researched, cross-referenced against current clinical literature, and verified for accuracy by the DTS editorial team. Platforms are re-evaluated monthly.
We're not therapists — we're researchers who spent hundreds of hours comparing these platforms so you don't have to. Some links on this page are affiliate links, meaning we may earn a commission if you sign up. This never influences which platforms we recommend or how honestly we report their limitations.
Pricing reflects our most recent research as of March 2026 and may vary by location and insurance plan. Confirm current pricing and insurance coverage directly with Cerebral before signing up. Regulatory history is based on publicly reported events as of our review date.